Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway
eLife · 2024
DOI: 10.7554/elife.94849 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Jianwen Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, United States. Hauptthemen laut MEDLINE: Interferon Type I, Membrane Proteins, N-Acetylglucosaminyltransferases, Nucleotidyltransferases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The O -GlcNAc transferase (OGT) is an essential enzyme that mediates protein O -GlcNAcylation, a unique form of posttranslational modification of many nuclear and cytosolic proteins. Recent studies observed increased OGT and O -GlcNAcylation levels in a broad range of human cancer tissues compared to adjacent normal tissues, indicating a universal effect of OGT in promoting tumorigenesis. Here, we show that OGT is essential for tumor growth in immunocompetent mice by repressing the cyclic GMP-AMP synthase (cGAS)-dependent DNA sensing pathway. We found that deletion of OGT ( Ogt −/− ) caused a marked reduction in tumor growth in both syngeneic mice tumor models and a genetic mice colorectal cancer (CRC) model induced by mutation of the Apc gene ( Apc min ). Pharmacological inhibition or genetic deletion of OGT induced a robust genomic instability (GIN), leading to cGAS-dependent production of the type I interferon (IFN-I) and IFN-stimulated genes (ISGs). As a result, deletion of Cgas or Sting from Ogt −/− cancer cells restored tumor growth, and this correlated with impaired CD8 + T-cell-mediated antitumor immunity. Mechanistically, we found that OGT-dependent cleavage of host cell factor C1 (HCF-1) is required for the avoidance of GIN and IFN-I production in tumors. In summary, our results identify OGT-mediated genomic stability and activate cGAS-STING pathway as an important tumor-cell-intrinsic mechanism to repress antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Infection and Immunity, Infectious Disease Institute, The Ohio State University, Columbus, United States.
- Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, United States.
- Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, United States.
- Department of Cancer Biology and Genetics, The Ohio State University, Columbus, United States.
- Department of Radiation Oncology, The Ohio State University, Columbus, United States.
- Department of Chemistry and Biochemistry, University of Delaware, Newark, United States.
ORCID-Profile: Hong Dong, Haitao Wen
Förderung
- NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- NIDCR NIH HHS
- The Ohio State University Comprehensive Cancer Center
- National Institutes of Health
Zitieren
APA
Chen, J., Zhao, B., Dong, H., Li, T., Cheng, X., Gong, W., Wang, J., Zhang, J., Xin, G., Yu, Y., Lei, Y. L., Black, J. D., Li, Z., & Wen, H. (2024). Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway. eLife. https://doi.org/10.7554/elife.94849
Vancouver
Chen J, Zhao B, Dong H, Li T, Cheng X, Gong W, et al. Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway. eLife. 2024. doi:10.7554/elife.94849
BibTeX
@article{Chen2024,
author = {Chen, Jianwen and Zhao, Bao and Dong, Hong and Li, Tianliang and Cheng, Xiang and Gong, Wang and Wang, Jing and Zhang, Junran and Xin, Gang and Yu, Yanbao and Lei, Yu L and Black, Jennifer D and Li, Zihai and Wen, Haitao},
title = {Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.94849}
}
EUVIMED